SEC Form 4 · accession 0001144204-15-040951
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Preti
Officer — See Remarks
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 9:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jun 30, 2015 | A | 1,578 | $1.5895 | A | 192,584 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares purchased pursuant to Caladrius Biosciences, Inc.'s 2012 Employee Stock Purchase Plan for the period ended June 30, 2015.
Remarks
Senior VP, Development and Technical Operations and Chief Technology Officer, Caladrius Biosciences and President, PCT, a Caladrius Company.